Guillain-Barré Syndrome in India: A Call for Learning and Cohesive Action

Area of Science:

• Neurology
• Immunology
• Infectious Diseases

Background:

• Guillain-Barré syndrome (GBS) is a rare immune-mediated polyradiculoneuropathy and a leading global cause of acute flaccid paralysis.
• GBS typically follows an infection, presenting with bilateral weakness, though variants can delay diagnosis.
• Knowledge of GBS pathophysiology, spectrum, and management has advanced since its initial description in 1859.

Purpose of the Study:

• To provide an overview of Guillain-Barré syndrome, including its pathophysiology, clinical presentation, and diagnostic approaches.
• To emphasize the importance of timely diagnosis and early initiation of immunomodulatory therapies for GBS.
• To highlight critical management aspects, including respiratory and autonomic monitoring, and the role of multidisciplinary care.

Main Methods:

• Clinical diagnosis is primary for GBS.
• Cerebrospinal fluid (CSF) analysis and electrodiagnostic tests support GBS diagnosis.
• Monitoring respiratory and autonomic function guides intensive care unit (ICU) management.

Main Results:

• Prompt diagnosis and early immunomodulatory therapy (IVIg or plasma exchange) are critical.
• Effective management relies on "time is nerve" principle, necessitating rapid treatment initiation.
• Holistic, multidisciplinary supportive care reduces GBS patient morbidity and mortality.

Conclusions:

• Early intervention with immunomodulatory therapy and comprehensive supportive care are vital for optimal GBS patient outcomes.
• Stakeholder and community involvement are essential for effective GBS prevention and treatment strategies.
• Addressing GBS outbreaks requires a coordinated local and national approach to public health.